Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M506172200 on January 5, 2006

J. Biol. Chem., Vol. 281, Issue 9, 5657-5667, March 3, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/9/5657    most recent
M506172200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anrather, J.
Right arrow Articles by Iadecola, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anrather, J.
Right arrow Articles by Iadecola, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

NF-{kappa}B Regulates Phagocytic NADPH Oxidase by Inducing the Expression of gp91phox*Formula

Josef Anrather1, Gianfranco Racchumi, and Costantino Iadecola

From the Division of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York 10021

The superoxide-generating phagocytic NADPH oxidase is an important component of the innate immune response against microbial agents, and is involved in shaping the cellular response to a variety of physiological and pathological signals. One of the downstream targets of NADPH oxidase-derived radicals is the ubiquitous transcription factor NF-{kappa}B, which controls the expression of a large array of genes involved in immune function and cell survival. Here we show that NF-{kappa}B itself is a key factor in controlling NADPH oxidase expression and function. In monocytic and microglial cell lines, the expression of the NADPH oxidase subunit gp91phox was induced by lipopolysaccharide/interferon {gamma} treatment and was inhibited in cells constitutively expressing I{kappa}B{alpha}. Furthermore, inducible reactive oxygen species production was inhibited in I{kappa}B{alpha} overexpressing cells. gp91phox expression was very low in RelA-/- fibroblasts and could be induced by reconstituting these cells with p65/RelA. Thus, gp91phox expression is dependent on the presence of p65/RelA. We also found that gp91phox transcription is dependent on NF-{kappa}B and we identified two potential cis-acting elements in the murine gp91phox promoter that control NF-{kappa}B-dependent regulation. The findings raise the possibility of a positive feedback loop in which NF-{kappa}B activation by oxidative stress leads to further radical production via NADPH oxidase.


Received for publication, June 7, 2005 , and in revised form, December 28, 2005.

* This work was supported by National Institutes of Health Grants HL077308 (to J. A.) and HL018974 (to C. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1 and Fig. S1.

1 To whom correspondence should be addressed: 411 East 69th St. KB410, New York, NY 10021. Tel.: 212-570-2900; Fax: 212-988-3672; E-mail: joa2006{at}med.cornell.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Chew, D. Y.C. Yuen, P. Koh, N. Stefanovic, M. A. Febbraio, I. Kola, M. E. Cooper, and J. B. de Haan
Site-Specific Antiatherogenic Effect of the Antioxidant Ebselen in the Diabetic Apolipoprotein E-Deficient Mouse
Arterioscler. Thromb. Vasc. Biol., June 1, 2009; 29(6): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Sanchez-Lemus, J. Benicky, J. Pavel, I. M. Larrayoz, J. Zhou, M. Baliova, T. Nishioku, and J. M. Saavedra
Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1376 - R1384.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. L. Pierce, L. A. Lesniewski, B. R. Lawson, S. D. Beske, and D. R. Seals
Nuclear Factor-{kappa}B Activation Contributes to Vascular Endothelial Dysfunction via Oxidative Stress in Overweight/Obese Middle-Aged and Older Humans
Circulation, March 10, 2009; 119(9): 1284 - 1292.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Girouard, G. Wang, E. F. Gallo, J. Anrather, P. Zhou, V. M. Pickel, and C. Iadecola
NMDA Receptor Activation Increases Free Radical Production through Nitric Oxide and NOX2
J. Neurosci., February 25, 2009; 29(8): 2545 - 2552.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-N. Peraldi, J. Berrou, N. Dulphy, A. Seidowsky, P. Haas, N. Boissel, F. Metivier, C. Randoux, N. Kossari, A. Guerin, et al.
Oxidative Stress Mediates a Reduced Expression of the Activating Receptor NKG2D in NK Cells from End-Stage Renal Disease Patients
J. Immunol., February 1, 2009; 182(3): 1696 - 1705.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Luengo-Blanco, C. Prando, J. Bustamante, W. C. Aragao-Filho, P. V. S. Pereira, J. Rehder, C. Padden, J.-L. Casanova, P. E. Newburger, and A. Condino-Neto
Essential role of nuclear factor-{kappa}B for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes
Blood, August 15, 2008; 112(4): 1453 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. B. Friis, K. G. Vorum, and I. H. Lambert
Volume-sensitive NADPH oxidase activity and taurine efflux in NIH3T3 mouse fibroblasts
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1552 - C1565.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Manea, S. A. Manea, A. V. Gafencu, M. Raicu, and M. Simionescu
AP-1-Dependent Transcriptional Regulation of NADPH Oxidase in Human Aortic Smooth Muscle Cells: Role of p22phox Subunit
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 878 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Ishizuka, J. Cheng, H. Singh, M. D. Vitto, V. L. Manthati, J. R. Falck, and M. Laniado-Schwartzman
20-Hydroxyeicosatetraenoic Acid Stimulates Nuclear Factor-{kappa}B Activation and the Production of Inflammatory Cytokines in Human Endothelial Cells
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 103 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. A. Gauss, L. K. Nelson-Overton, D. W. Siemsen, Y. Gao, F. R. DeLeo, and M. T. Quinn
Role of NF-{kappa}B in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-{alpha}
J. Leukoc. Biol., September 1, 2007; 82(3): 729 - 741.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Qian, K. S. Tan, S.-J. Wei, H.-M. Wu, Z. Xu, B. Wilson, R.-B. Lu, J.-S. Hong, and P. M. Flood
Microglia-Mediated Neurotoxicity Is Inhibited by Morphine through an Opioid Receptor-Independent Reduction of NADPH Oxidase Activity
J. Immunol., July 15, 2007; 179(2): 1198 - 1209.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Lewis, N. Stefanovic, J. Pete, A. C. Calkin, S. Giunti, V. Thallas-Bonke, K. A. Jandeleit-Dahm, T. J. Allen, I. Kola, M. E. Cooper, et al.
Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice
Circulation, April 24, 2007; 115(16): 2178 - 2187.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. L. Figarola, N. Shanmugam, R. Natarajan, and S. Rahbar
Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes
Diabetes, March 1, 2007; 56(3): 647 - 655.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Nakata, M. Tsutsui, H. Shimokawa, T. Yamashita, A. Tanimoto, H. Tasaki, K. Ozumi, K. Sabanai, T. Morishita, O. Suda, et al.
Statin Treatment Upregulates Vascular Neuronal Nitric Oxide Synthase Through Akt/NF-{kappa}B Pathway
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 92 - 98.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. D. Hingtgen, X. Tian, J. Yang, S. M. Dunlay, A. S. Peek, Y. Wu, R. V. Sharma, J. F. Engelhardt, and R. L. Davisson
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy
Physiol Genomics, September 14, 2006; 26(3): 180 - 191.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement